Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium.
about
Gene therapy for ischemic heart diseaseCardiovascular gene therapy for myocardial infarctionSPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular diseaseMyocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeabilityA novel chimeric promoter that is highly responsive to hypoxia and metals.Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.Therapeutic angiogenesis in critical limb and myocardial ischemia.Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review.Gene therapy for cardiovascular angiogenesis.Chronic therapeutically refractory angina pectorisTherapeutic angiogenesis using vascular endothelial growth factor.Cardiac overexpression of human VEGF(165) by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failureGene targeting in ischemic heart disease and failure: translational and clinical studies.Reduction of endothelial dysfunction following VEGF gene therapy.Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardiumHistopathological validation of electromechanical mapping in assessing myocardial viability in a porcine model of chronic ischemia.Gene and stem cell therapy in peripheral arterial occlusive disease.Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials.Cardiac gene therapy in large animals: bridge from bench to bedside.Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success.Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography.Treatment of avascular necrosis of the femoral head by hepatocyte growth factor-transgenic bone marrow stromal stem cells.Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure.Critical appraisal of the mouse model of myocardial infarction.Catheter-based transendocardial myocardial gene transfer.Evaluation of the porcine ameroid constrictor model of myocardial ischemia for therapeutic angiogenesis studies.Effects of intramyocardial pVEGF165 delivery on regional myocardial blood flow: evidence for a spatial 'delivery-efficacy' mismatch.Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system.Functional characteristics of coronary vasomotor function following intramyocardial gene therapy with naked DNA encoding for vascular endothelial growth factor165.Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients
P2860
Q24632135-82C5F563-A75B-4939-AE6A-5BE036BB4D46Q27014770-889EAFAC-8BA4-4464-BC29-DC2D9E20BC6EQ28066121-D06495ED-4B5C-45D9-A4BE-50DCDB880805Q30440788-4EDD0FB4-0E95-4AE6-B065-4964AFAABB24Q33233475-AAC1A6F8-3FA7-4D68-9F76-1D8AFF92BB7EQ34482530-C19F395F-8172-49C2-9086-F0BF263B165AQ34515181-5310499C-D1B4-4A4A-BEDA-7F752BC12B20Q34675242-7E19FA09-6F39-420C-9732-322C5E1370D3Q35080395-B700F0BB-2474-4FE0-8CDF-104788B636AFQ35164797-C3B7C6F3-5F59-43E4-9FDF-1674567364F3Q35632174-38A1806B-E5A9-44F9-A156-C460BA7B7E01Q35814821-BF5CEB52-0312-4CCC-AC37-D5D8EEFA5FE8Q36298232-B1324E73-6AD3-40ED-AE9F-1F26F25ABE73Q36617570-4E41020C-EE20-4CA0-9A35-99B4087E09A5Q36813231-25685A60-6F54-405A-B5E0-AE5D35C064B0Q37085665-E4D6FE94-DB02-4BEE-A135-803E3A79264EQ37145757-0B889508-A808-49C2-8BAD-02272B1A5F7CQ37204529-A1972C01-53E4-451B-B09F-039D6C2C390FQ37961586-3AF73621-D55F-49F8-B225-A40D29E17319Q37981008-C3F4F348-84E9-41E6-9667-4D4069CF7FEDQ38087578-9870B4C6-7C0C-408D-B2C9-FAA9EA332FF5Q38132253-923D9A6F-F02E-4842-B423-BDF43002B48CQ39275479-3F85C844-E7F7-4837-8ACF-2D6EC39A6D9DQ43603871-52D6F89D-C272-40C8-8370-3969680BEB1DQ43621188-758C40AC-C9DE-4C44-8986-554FD912A9ABQ43831854-69DAC7E4-6779-41CF-8152-3E20B307AC8BQ44020269-41FCB5DA-DD81-465D-9F10-68ABE4011579Q45861500-984129A6-3F1D-4278-8CE4-2714CD08D501Q45876218-B4936C49-C67D-4761-B8E5-D755E7690DD6Q45876516-FF2F37BC-8609-4C25-B578-CD7E45E3CC4EQ45888619-32C8D9FC-A786-4730-A928-0B7E7D64CD3FQ57307075-D4C518B2-6734-4373-BB57-47E23B9C1D14
P2860
Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Intramyocardial gene therapy w ...... l flow to ischemic myocardium.
@en
Intramyocardial gene therapy w ...... l flow to ischemic myocardium.
@nl
type
label
Intramyocardial gene therapy w ...... l flow to ischemic myocardium.
@en
Intramyocardial gene therapy w ...... l flow to ischemic myocardium.
@nl
prefLabel
Intramyocardial gene therapy w ...... l flow to ischemic myocardium.
@en
Intramyocardial gene therapy w ...... l flow to ischemic myocardium.
@nl
P2093
P1433
P1476
Intramyocardial gene therapy w ...... l flow to ischemic myocardium.
@en
P2093
Scheuermann TH
Tkebuchava T
P304
P356
10.1089/10430349950016366
P577
1999-12-01T00:00:00Z